DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

AbbVie Inc. (NYSE: ABBV)

66.98 0.77 (1.16%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABBV $66.98 1.16%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $66.51
Previous Close $66.21
Daily Range $66.51 - $67.24
52-Week Range $45.50 - $70.76
Market Cap $106.7B
P/E Ratio 28.79
Dividend (Yield) $1.96 (3.0%)
Ex-Dividend Date
Dividend Pay Date
01/13/15
02/13/15
Volume 4,158,049
Average Daily Volume 7,010,606
Current FY EPS $3.30

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary

Is Gilead Sciences, Inc. a Value Stock Following Its Tumble?

Gilead Sciences' slate of catalysts and a forward P/E of less than 10 make it intriguing.

3 Biotech Stocks That Could Double in 2015

Three Motley Fool contributors tell us which biotech stocks they think could make a big move next year.

Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens

Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.

Costly new drugs have driven pharma stock prices to all-time highs over the last two years. Here's why this trend might come to a screeching halt.

Billionaires Are Buying More of These 3 Stocks

Hedge funds have been buying more and more of these three stocks in recent months.

Should AbbVie Inc. and Gilead Sciences, Inc. Fear This Biotech Instead of Each Other?

Achillion Pharmaceuticals ACH-3102 helps cure hepatitis C patients more quickly than Gilead Sciences and AbbVie.

Ideal Level for Oil?; Heed the Rotation: Jim Cramer's Best Blogs

3 Stocks Poised for Eye-Popping Gains in 2015

Gilead Sciences, Orexigen Therapeutics, and Prothena Corp. are all poised to have a huge 2015. Here's what investors need to know.

Novartis' Alcon's Travatan Obtains Label Expansion in the EU - Analyst Blog

Roche' (RHHBY) Blood Cancer Drug Gazyva's Label Updated - Analyst Blog

See More ABBV News...